Rahul Tatineni

Rahul Tatineni

Active Director Director DIN 06670419
DIN 06670419 First appointment May 2018 Primary industry Infrastructure and Utilities
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since May 2018
Shareholding value •••• Premium profile

About Rahul Tatineni

Data last updated:

Rahul Tatineni is a Director at Gaia Infra Projects Private Limited (since 2019), Director at Prontgen Health Remedies Private Limited (since 2024) and Director at Wishmen Lifesciences Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Infrastructure and Utilities, Pharma and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹1.50 Cr; the largest is Gaia Infra Projects Private Limited at ₹58.7 Lakh (FY 2025).

DIN 06670419
Primary Designation Director
Industry Infrastructure and Utilities
First Appointment 05 May 2018
Oldest Company Age 18 yrs
Largest company Gaia Infra Projects Private Limited · ₹58.7 Lakh (FY 2025)
Combined revenue ₹1.50 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gaia Infra Projects Private Limited U45200TG2008PTC058517
Director15 Jun 20192008₹58.7 Lakh (FY 2025)Active
Director03 Sep 20242018₹46.6 Lakh (FY 2024)Active
Wishmen Lifesciences Private Limited U46497TS2024PTC187865
Director25 Jul 20242024₹42.7 Lakh (FY 2025)Active
Ambrosia Wellness Private Limited U85191TG2010PTC069349
Director05 Aug 20192010₹2.4 Lakh (FY 2025)Active
Designated Partner02 Jun 20262026Active
Director05 May 20182014Active

Directorship timeline

Open interactive timeline →
Wishmen Lifesciences Private Limited
Ambrosia Wellness Private Limited
Gaia Infra Projects Private Limited
Tuscan Orient Projects Private Limited
Premium access

Shareholding and investment profile for Rahul Tatineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Tatineni

Rahul Tatineni currently holds 6 directorships: Gaia Infra Projects Private Limited (Director, since 15 Jun 2019, revenue ₹58.7 Lakh (FY 2025)); Prontgen Health Remedies Private Limited (Director, since 03 Sep 2024, revenue ₹46.6 Lakh (FY 2024)); Wishmen Lifesciences Private Limited (Director, since 25 Jul 2024, revenue ₹42.7 Lakh (FY 2025)); Ambrosia Wellness Private Limited (Director, since 05 Aug 2019, revenue ₹2.4 Lakh (FY 2025)); Krishya Pharma Llp (Designated Partner, since 02 Jun 2026); and 1 more.

Rahul Tatineni was first appointed on 05 May 2018 as Director at Tuscan Orient Projects Private Limited. The most recent appointment on record is 02 Jun 2026 at Krishya Pharma Llp.

The 4 current companies of Rahul Tatineni that report revenue have a combined latest revenue of ₹1.50 Cr: Gaia Infra Projects Private Limited ₹58.7 Lakh (FY 2025); Prontgen Health Remedies Private Limited ₹46.6 Lakh (FY 2024); Wishmen Lifesciences Private Limited ₹42.7 Lakh (FY 2025); Ambrosia Wellness Private Limited ₹2.4 Lakh (FY 2025).

The current boards of Rahul Tatineni's companies include Rohit Tatineni (Gaia Infra Projects Private Limited), Tatineni Shyamala (Gaia Infra Projects Private Limited), Pavan Kumar Kothapuvari (Prontgen Health Remedies Private Limited), Venupriya Durgam (Prontgen Health Remedies Private Limited), Ayalasomayajula Chakravarthi Aditya (Wishmen Lifesciences Private Limited), Narasimharao Nv Lakshmi Vemparala (Wishmen Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available